These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28826021)

  • 1. EEG-arousal regulation as predictor of treatment response in patients suffering from obsessive compulsive disorder.
    Dohrmann AL; Stengler K; Jahn I; Olbrich S
    Clin Neurophysiol; 2017 Oct; 128(10):1906-1914. PubMed ID: 28826021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate variability in obsessive compulsive disorder in comparison to healthy controls and as predictor of treatment response.
    Olbrich H; Jahn I; Stengler K; Seifritz E; Colla M
    Clin Neurophysiol; 2022 Jun; 138():123-131. PubMed ID: 35390760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EEG-vigilance regulation during the resting state in obsessive-compulsive disorder.
    Olbrich S; Olbrich H; Jahn I; Sander C; Adamaszek M; Hegerl U; Reque F; Stengler K
    Clin Neurophysiol; 2013 Mar; 124(3):497-502. PubMed ID: 23022038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Review and Recommendations of Evidence-Based Treatments for Pediatric Obsessive-Compulsive Disorder].
    Skarphedinsson G; Lauth B; Njardvik U; Ivarsson T
    Laeknabladid; 2016 Apr; 102(4):179-85. PubMed ID: 27197125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What Is the Added Benefit of Combining Cognitive Behavioral Therapy and Selective Serotonin Reuptake Inhibitors in Youth with Obsessive Compulsive Disorder? A Bayesian Hierarchical Modeling Meta-Analysis.
    Mendez EM; Dahlsgaard KK; Hjelmgren JM; Mills JA; Suresh V; Strawn JR
    J Child Adolesc Psychopharmacol; 2023 Aug; 33(6):203-211. PubMed ID: 37347947
    [No Abstract]   [Full Text] [Related]  

  • 6. How resistant is 'treatment-resistant' obsessive-compulsive disorder in youth?
    Krebs G; Isomura K; Lang K; Jassi A; Heyman I; Diamond H; Advani J; Turner C; Mataix-Cols D
    Br J Clin Psychol; 2015 Mar; 54(1):63-75. PubMed ID: 25130442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining response in clinical trials for obsessive-compulsive disorder: a signal detection analysis of the Yale-Brown obsessive compulsive scale.
    Tolin DF; Abramowitz JS; Diefenbach GJ
    J Clin Psychiatry; 2005 Dec; 66(12):1549-57. PubMed ID: 16401156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
    Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
    J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of cognitive-behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine.
    Kampman M; Keijsers GP; Hoogduin CA; Verbraak MJ
    Acta Psychiatr Scand; 2002 Oct; 106(4):314-9. PubMed ID: 12225499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining Drug and Psychological Treatments for Obsessive- Compulsive Disorder: What is the Evidence, When and for Whom.
    Albert U; Di Salvo G; Solia F; Rosso G; Maina G
    Curr Med Chem; 2018; 25(41):5632-5646. PubMed ID: 28707590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pediatric obsessive-compulsive disorder: a review.
    Mancuso E; Faro A; Joshi G; Geller DA
    J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):299-308. PubMed ID: 20807068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mindfulness-based cognitive therapy in obsessive-compulsive disorder: protocol of a randomized controlled trial.
    Külz AK; Landmann S; Cludius B; Hottenrott B; Rose N; Heidenreich T; Hertenstein E; Voderholzer U; Moritz S
    BMC Psychiatry; 2014 Nov; 14():314. PubMed ID: 25403813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain arousal regulation in SSRI-medicated patients with major depression.
    Ulke C; Wittekind DA; Spada J; Franik K; Jawinski P; Hensch T; Hegerl U
    J Psychiatr Res; 2019 Jan; 108():34-39. PubMed ID: 30448695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct trajectories of long-term symptom severity in pediatric obsessive-compulsive disorder during and after stepped-care treatment.
    Jensen S; Højgaard DRMA; Hybel KA; Mortensen EL; Skarphedinsson G; Melin K; Ivarsson T; Nissen JB; Weidle B; Valderhaug R; Torp NC; Dahl K; Compton S; Thomsen PH
    J Child Psychol Psychiatry; 2020 Sep; 61(9):969-978. PubMed ID: 31736082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional connectivity of the raphe nucleus as a predictor of the response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Kim M; Kwak S; Yoon YB; Kwak YB; Kim T; Cho KIK; Lee TY; Kwon JS
    Neuropsychopharmacology; 2019 Nov; 44(12):2073-2081. PubMed ID: 31189178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in the pharmacological treatment of obsessive-compulsive disorder.
    Math SB; Janardhan Reddy YC
    Int J Clin Pract; 2007 Jul; 61(7):1188-97. PubMed ID: 17511795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
    Pediatric OCD Treatment Study (POTS) Team
    JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
    Tundo A; Salvati L; Busto G; Di Spigno D; Falcini R
    J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obsessive-compulsive disorder. Diagnosis and management.
    Ladouceur R; Freeston M; Gagnon F
    Can Fam Physician; 1996 Jun; 42():1169-72, 1175-8. PubMed ID: 8704492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary outcomes from the pediatric obsessive compulsive disorder treatment study II.
    Conelea CA; Selles RR; Benito KG; Walther MM; Machan JT; Garcia AM; Sapyta J; Morris S; Franklin M; Freeman JB
    J Psychiatr Res; 2017 Sep; 92():94-100. PubMed ID: 28412602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.